Floatz logo

Fosphenytoin

CLL (Chronic Lymphocytic Leukemia)

Center for International Blood and Marrow Transplant ResearchSmall moleculePhase 2Active
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
36/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the CLL (Chronic Lymphocytic Leukemia) cohort.

Asset / SponsorPhaseRating
Ruxolitinib
Center for International Blood and Marrow Transplant Research
Phase 3BB
TACROLIMUS
Center for International Blood and Marrow Transplant Research
Phase 2B
Palifermin
Center for International Blood and Marrow Transplant Research
Phase 2CCC
ABATACEPT RECOMBINANT
Center for International Blood and Marrow Transplant Research
Phase 2CCC
Ptcy
Center for International Blood and Marrow Transplant Research
Phase 2CCC

View all 11 →

Same molecule, other indications

Fosphenytoin is also rated in:

epilepsy with generalized tonic-clonic seizuresDormant
B
Indicative ·
61 / 100
View asset →
brain hypoxia - ischemiaDormant
B
Indicative ·
58 / 100
View asset →
traumatic brain injuryDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →